← Back to Search

Brief Parent-Teen Dating Violence Prevention Program for Adolescent Violence (ETHR Trial)

N/A

Waitlist Available

Research Sponsored by University of Pittsburgh

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up through completion of completing 3 month post-intervention survey, an average of 12 months

Awards & highlights

No Placebo-Only Group

Summary

This trial studies if a brief parent-teen dating violence prevention program is feasible & acceptable in pediatric primary care. 4 healthcare providers will deliver it & compare it to routine well-child care.

Who is the study for?

This trial is for English-speaking pediatricians, nurse practitioners, or physician assistants and their patients aged 11 to 15 who have an upcoming well-child visit. It also includes the caregivers of these adolescents if they are attending the visit and speak English.

What is being tested?

The study tests a brief intervention called Engaging Together for Healthy Relationships (ETHR) aimed at preventing dating violence among adolescents. ETHR will be delivered during routine pediatric care visits and compared with standard well-child care.

What are the potential side effects?

Since this trial involves educational interventions rather than medical treatments, there are no direct physical side effects expected from participating in this study.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ through completion of completing 3 month post-intervention survey, an average of 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~through completion of completing 3 month post-intervention survey, an average of 12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and through completion of completing 3 month post-intervention survey, an average of 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Percentage of participants who are consented out of the total who are eligible

Percentage of participants who are eligible out of the total who are approached

Percentage of participants who complete the 1-month post-intervention survey out of the total who consented

+5 more

Secondary study objectives

Attitudes about ARA, change in outcome between baseline and 3 months

Parent-adolescent communication around dating and ARA, change in outcome over time

Parental monitoring around dating and ARA, change in outcome over time

+3 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Intervention (Engaging Together for Healthy Relationships)Experimental Treatment1 Intervention

Providers and families in the intervention arm will receive the ETHR program which includes a clinician training, provider scripts, resource guides, a comprehensive website, and warm referral processes.

Group II: Control (Receipt of regular well-child care)Active Control1 Intervention

Providers and families in the control arm will receive regular well-child care. All providers in the control arm will have access to ETHR after the pilot trial is over

Do I qualify?Apply below to find out